José Federico
Díaz González
Full Professor
Hospital General Universitario de Alicante
Alicante, EspañaPublications in collaboration with researchers from Hospital General Universitario de Alicante (9)
2022
2021
-
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study
RMD Open, Vol. 7, Núm. 3
-
Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply
Rheumatology (Oxford, England), Vol. 60, Núm. 3, pp. e120-e121
-
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
Scientific Reports, Vol. 11, Núm. 1
2020
-
Prevalence of systemic lupus erythematosus in Spain: Higher than previously reported in other countries?
Rheumatology (United Kingdom), Vol. 59, Núm. 9, pp. 2556-2562
-
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: Data from the BIOBADASER III register
Arthritis Research and Therapy, Vol. 22, Núm. 1
-
Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study
Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170
2019
-
Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96
-
Objectives and methodology of BIOBADASER phase III
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236